PLEASE CONTACT THE STUDY COORDINATOR FOR THE TRIAL  OR THE ACADEMIC OFFICE OF CLINICAL TRIALS MAIN LINE AT 713.441.3250
FEATURED CLINICAL TRIALS
Imaging study to predict treatment intensity in those at risk for heart disease

The study will examine if cardiac CT imaging results can be used to guide the intensity of medical therapy for lipid and blood pressure management in patients with metabolic syndrome or at intermediate/high-risk for atherosclerotic cardiovascular disease. 

Clinical Trial:TEAL study for breast cancer
Breast Cancer

This study will evaluate the Pathological Complete Response, which refers to complete disappearance of a tumor from the breast, when trastuzumab emtansine (TDM-1), lapatinib and Abraxane® are combined. This study is for patients with newly diagnosed HER2 positive breast cancer. 

Learn more about assessing the toxicity, safety and efficacy of the drug combination >

Civacir® Polyclonal Immune Globulin (IgG)

The purpose of this study is to test the safety and efficacy of Civacir® to prevent the recurrence of Hepatitis C Virus (HCV) after liver transplant.

Learn more > 

More to Explore